XML 49 R36.htm IDEA: XBRL DOCUMENT v3.25.0.1
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Summary of Stock Option

The fair value of stock options is recorded as compensation expense on a straight-line basis over the vesting periods (which approximates the requisite service period) of the options and forfeitures are accounted for when they occur.

Information related to all stock options under the 2021 Plan, 2017 Plan and 2007 Plan, and the 2020 Inducement Awards for 2024, 2023 and 2022 is shown in the tables below:

(Shares in thousands)

 

Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term

 

Aggregate
Intrinsic
Value
($000)

 

Outstanding at December 31, 2023

 

 

1,247

 

 

$

11.09

 

 

3.4 years

 

 

 

Grants

 

 

25

 

 

 

21.32

 

 

 

 

 

 

Forfeitures

 

 

(2

)

 

 

13.08

 

 

 

 

 

 

Exercised

 

 

(28

)

 

 

12.09

 

 

 

 

 

 

Outstanding and expected to vest at December 31, 2024

 

 

1,242

 

 

 

11.35

 

 

2.6 years

 

$

23,902

 

Exercisable at December 31, 2024

 

 

1,216

 

 

 

11.15

 

 

2.5 years

 

$

23,676

 

 

(Shares in thousands)

 

Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term

 

Aggregate
Intrinsic
Value
($000)

 

Outstanding at December 31, 2022

 

 

1,440

 

 

$

11.30

 

 

4.0 years

 

 

 

Forfeitures

 

 

(92

)

 

 

13.43

 

 

 

 

 

 

Exercised

 

 

(101

)

 

 

11.93

 

 

 

 

 

 

Outstanding and expected to vest at December 31, 2023

 

 

1,247

 

 

 

11.09

 

 

3.4 years

 

$

11,452

 

Exercisable at December 31, 2023

 

 

942

 

 

 

11.10

 

 

3.4 years

 

$

8,652

 

 

(Shares in thousands)

 

Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term

 

Aggregate
Intrinsic
Value
($000)

 

Outstanding at December 31, 2021

 

 

1,514

 

 

$

11.19

 

 

4.9 years

 

 

 

Forfeitures

 

 

(32

)

 

 

10.55

 

 

 

 

 

 

Exercised

 

 

(42

)

 

 

8.15

 

 

 

 

 

 

Outstanding and expected to vest at December 31, 2022

 

 

1,440

 

 

 

11.30

 

 

4.0 years

 

$

1,766

 

Exercisable at December 31, 2022

 

 

833

 

 

 

11.47

 

 

3.6 years

 

$

923

 

Summary of Restricted Stock Awards

Information related to restricted stock awards under the 2021 Plan, 2017 Plan, 2007 Plan, and the 2020 Inducement Awards for 2024, 2023 and 2022 is shown in the table below. The fair value of restricted stock awards is based on the price of the stock in the open market on the date of the grant, and the fair value of performance-based restricted stock units is determined by using the Monte Carlo valuation model. The fair value of the restricted stock awards is recorded as compensation expense on a straight-line basis over the vesting periods of the awards and forfeitures are accounted for when they occur.

 

(Shares in thousands)

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Nonvested at December 31, 2021

 

 

1,033

 

 

$

7.17

 

Granted

 

 

755

 

 

 

5.74

 

Vested

 

 

(355

)

 

 

6.80

 

Forfeited

 

 

(255

)

 

 

6.41

 

Nonvested at December 31, 2022

 

 

1,178

 

 

 

6.53

 

Granted

 

 

734

 

 

 

16.12

 

Vested

 

 

(417

)

 

 

6.56

 

Forfeited

 

 

(174

)

 

 

7.19

 

Nonvested at December 31, 2023

 

 

1,321

 

 

 

11.77

 

Granted

 

 

356

 

 

 

22.03

 

Vested

 

 

(409

)

 

 

9.19

 

Forfeited

 

 

(74

)

 

 

14.29

 

Nonvested at December 31, 2024

 

 

1,194

 

 

 

14.98